Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland R Griffiths

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Psychopharmacology|August 1, 2018
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognitionFrederick S Barrett, Theresa M Carbonaro, Ethan Hurwitz, et al.
Journal of Psychopharmacology (Oxford, England)|June 26, 2018
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accountsTehseen Noorani, Albert Garcia-Romeu, Thomas C Swift, et al.
Journal of Psychopharmacology (Oxford, England)|June 9, 2023
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant useNatalie Gukasyan, Roland R Griffiths, David B Yaden, et al.
Current Topics in Behavioral Neurosciences|December 27, 2021
The Potential of Psychedelics for End of Life and Palliative CareDavid B Yaden, Sandeep M Nayak, Natalie Gukasyan, et al.
Plos One|April 24, 2019
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMTRoland R Griffiths, Ethan S Hurwitz, Alan K Davis, et al.
Experimental and Clinical Psychopharmacology|September 21, 2011
Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly useBethea A Kleykamp, Roland R Griffiths, Una D McCann, et al.
Journal of Psychopharmacology (Oxford, England)|February 22, 2021
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approachesAlbert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, et al.
Journal of Affective Disorders|December 30, 2022
Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptomsAki Nikolaidis, Rafaelle Lancelotta, Natalie Gukasyan, et al.
Scientific Reports|February 12, 2020
Emotions and brain function are altered up to one month after a single high dose of psilocybinFrederick S Barrett, Manoj K Doss, Nathan D Sepeda, et al.
Neuroimage|May 27, 2020
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attentionFrederick S Barrett, Samuel R Krimmel, Roland R Griffiths, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Psychopharmacology|August 1, 2018
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognitionFrederick S Barrett, Theresa M Carbonaro, Ethan Hurwitz, et al.
Journal of Psychopharmacology (Oxford, England)|June 26, 2018
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accountsTehseen Noorani, Albert Garcia-Romeu, Thomas C Swift, et al.
Journal of Psychopharmacology (Oxford, England)|June 9, 2023
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant useNatalie Gukasyan, Roland R Griffiths, David B Yaden, et al.
Current Topics in Behavioral Neurosciences|December 27, 2021
The Potential of Psychedelics for End of Life and Palliative CareDavid B Yaden, Sandeep M Nayak, Natalie Gukasyan, et al.
Plos One|April 24, 2019
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMTRoland R Griffiths, Ethan S Hurwitz, Alan K Davis, et al.
Experimental and Clinical Psychopharmacology|September 21, 2011
Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly useBethea A Kleykamp, Roland R Griffiths, Una D McCann, et al.
Journal of Psychopharmacology (Oxford, England)|February 22, 2021
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approachesAlbert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, et al.
Journal of Affective Disorders|December 30, 2022
Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptomsAki Nikolaidis, Rafaelle Lancelotta, Natalie Gukasyan, et al.
Scientific Reports|February 12, 2020
Emotions and brain function are altered up to one month after a single high dose of psilocybinFrederick S Barrett, Manoj K Doss, Nathan D Sepeda, et al.
Neuroimage|May 27, 2020
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attentionFrederick S Barrett, Samuel R Krimmel, Roland R Griffiths, et al.
Pageof 14